Back to Duquesne Family Office LLC Duquesne Family Office LLC

PTGXPTGX
3 quarters

Position history for Duquesne Family Office LLCDuquesne Family Office LLC's holdings in PROTAGONIST THERAPEUTICS INC

Duquesne Family Office LLC holds 159,700 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $16.8M as of 2026-Q1. PTGX represents 0.5% of Duquesne Family Office LLC's portfolio.

Current Value

$16.8M

Current Shares

159,700

Total Value Change

+$6.2M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
159,700
0.0%
$16.8M0.5%$91.30
0
2025-Q4
Unchanged
159,700
0.0%
$13.9M0.3%$87.26
0
2025-Q3
New
159,700
-
$10.6M0.3%$65.14
46

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C., UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used